We are live on ! Find out more
TNGX icon

Tango Therapeutics
TNGX

72 hedge funds and large institutions have $528M invested in Tango Therapeutics in 2022 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 23 increasing their positions, 11 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

233% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 6

109% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 11

24% more funds holding

Funds holding: 58 → 72 (+14)

2.18% more ownership

Funds ownership: 77.41% → 79.59% (+2.2%)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

29% less capital invested

Capital invested by funds: $741M → $528M (-$213M)

Holders
72
Holders Change
+14
Holders Change %
+24.14%
% of All Funds
1.14%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
20
Increased
23
Reduced
11
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$11M
2
TCM
TCG Crossover Management
California
+$10.9M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$8.67M
4
SCA
Southpoint Capital Advisors
New York
+$6.98M
5
Millennium Management
Millennium Management
New York
+$4.21M

Top Sellers

Rank Fund Capital Flow
1
HA
HHLR Advisors
Cayman Islands
-$25.9M
2
EC
EcoR1 Capital
California
-$4.66M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.65M
4
RI
RTW Investments
New York
-$1.98M
5
Citadel Advisors
Citadel Advisors
Florida
-$546K
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
26
Susquehanna International Group
Pennsylvania
$2.52M +$1.86M +215,120 +184%
FCM
27
Farallon Capital Management
California
$2.27M – – –
State Street
28
State Street
Massachusetts
$1.87M +$149K +17,141 +7%
ECM
29
ExodusPoint Capital Management
New York
$1.46M +$1.1M +126,824 +194%
Barclays
30
Barclays
United Kingdom
$932K +$1.07M +122,909 New
Northern Trust
31
Northern Trust
Illinois
$921K -$26K -3,005 -2%
Ensign Peak Advisors
32
Ensign Peak Advisors
Utah
$801K – – –
Goldman Sachs
33
Goldman Sachs
New York
$772K +$166K +19,180 +23%
NCM
34
Nantahala Capital Management
Connecticut
$749K -$10.5K -1,206 -1%
Swiss National Bank
35
Swiss National Bank
Switzerland
$706K +$55.5K +6,400 +7%
Squarepoint
36
Squarepoint
New York
$633K +$724K +83,555 New
PVI
37
Pura Vida Investments
New York
$627K +$4.33K +500 +0.6%
Bank of America
38
Bank of America
North Carolina
$606K -$121K -13,977 -15%
Alyeska Investment Group
39
Alyeska Investment Group
Illinois
$563K -$433K -50,000 -40%
CSS
40
Cubist Systematic Strategies
Connecticut
$439K +$502K +57,880 New
N
41
Nuveen
North Carolina
$338K +$384K +44,279 New
SM
42
Sciencast Management
New Jersey
$290K +$315K +36,322 New
Citigroup
43
Citigroup
New York
$278K +$37K +4,267 +13%
WAM
44
Weiss Asset Management
Massachusetts
$258K +$295K +34,000 New
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$255K +$2.83K +326 +1%
Jane Street
46
Jane Street
New York
$248K +$283K +32,656 New
State of Wisconsin Investment Board
47
State of Wisconsin Investment Board
Wisconsin
$247K +$283K +32,600 New
Balyasny Asset Management
48
Balyasny Asset Management
Illinois
$241K +$275K +31,781 New
Marshall Wace
49
Marshall Wace
United Kingdom
$220K +$196K +22,646 +361%
AH
50
Aviva Holdings
Bahamas
$204K – – –
1
2
3 4

TNGX Hedge Fund Activity: Q1 2022 in Review

72 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Tango Therapeutics (TNGX) for Q1 2022, worth a combined $528M — down 29% from $741M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new TNGX positions and 6 closed out — a net gain of 14 holders — while 23 added to existing stakes and 11 trimmed.

The largest buyer was Vanguard Group, adding an estimated $11M. The largest seller was HHLR Advisors, cutting an estimated $25.9M.

  • 72 institutional investors held Tango Therapeutics (TNGX) as of Q1 2022, up from 58 in Q4 2021.
  • Funds reported $528M of Tango Therapeutics stock for Q1 2022, down 29% quarter-over-quarter.
  • 20 funds opened new Tango Therapeutics positions in Q1 2022 and 6 closed out, a net change of +14 holders.
  • The largest Tango Therapeutics buyer in Q1 2022 was Vanguard Group, an estimated $11M added.
  • The largest Tango Therapeutics seller in Q1 2022 was HHLR Advisors, an estimated $25.9M sold.

Based on aggregated 13F filings for Q1 2022.